JAS Worldwide has appointed David Bang as executive vice president for global pharma & healthcare, as the forwarder aims to build and lead in this vertical.

David has more than 20 years of experience in logistics, supply chain, healthcare, and life sciences. As former global VP for strategic development at Hellmann, David spearheaded the global development of the company’s healthcare network. He also served as board member of Rx-360, a nonprofit that addresses patient safety and product integrity, as well as MaxQ Research, a shipping systems provider for sensitive biologics.

Also read: Kuehne+Nagel teams up with pharma distributor Jointown

In 2005, he co-founded LifeConEx, a joint venture between DHL and Lufthansa Airlines that provides logistics solutions for the bio-pharma industry, and became CEO in 2006. Under his leadership, David expanded the network to more than 100 stations in 65 countries.

“David’s extensive accomplishments and leadership in the pharmaceutical and healthcare sectors, along with his vision and passion for developing programs that deliver value to pharma and healthcare manufacturers and distributors, makes him the perfect candidate to build and lead this vertical”, said JAS chief commercial officer, Carol Kijac.

“JAS will be making significant investments in resources, infrastructure and product development in this vertical and with David at the helm, we are confident we will have a strong, compliant service offering to support clients in this vertical”, added CEO Marco Rebuffi.